Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS · Natera, Inc.
- 2024
- Oct 3, 2026
- 35
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Solomon Moshkevich files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Matthew Rabinowitz - $124.05M in NTRA purchases and sales in the last 12 months
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
- Roelof Botha - $34.89M in NTRA purchases and sales in the last 12 months
- Jonathan Sheena - $28.00M in NTRA purchases and sales in the last 12 months
- Daniel Rabinowitz - $23.61M in NTRA purchases and sales in the last 12 months
- Michael Burkes Brophy - $21.73M in NTRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Solomon Moshkevich?
Solomon Moshkevich is a corporate insider, tracked as PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc. (NTRA). InsiderAlpha holds 35 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Solomon Moshkevich submitted recently?
5 primary Form 4 filings in the last 90 days, covering 1 company.
Has Solomon Moshkevich been buying or selling stock?
Recorded transactions: 0 open-market purchases and 87 open-market sales ($26.99M) across all tracked filings.
